Newborn Genomic Screening: In Sickness and In Health

Over the past decade, advances in high-throughput genome sequencing together with dramatic cost reductions have transformed basic research and clinical medicine. Exome- and whole-genome analysis are becoming routine aspects of medical care, advancing the diagnosis and treatment of rare genetic disorders and a variety of cancers. Genome sequencing and analysis is having a profound impact on newborn care, both in helping solve diagnostic odysseys of newborns in intensive care and in monitoring the long-term benefits of genomic medicine.

In this inaugural Clinical OMICs Keynote webinar, we are proud to host two renowned leaders in the field of genomic medicine, Drs Stephen Kingsmore and Robert Green, who will discuss their pioneering work in the field of newborn genome sequencing and analysis:

• Dr. Stephen Kingsmore will present his trailblazing work at Rady Children’s Hospital, developing a rapid, complete sample-to-diagnosis pipeline that has provided multiple life-changing diagnoses for sick babies.
• Dr. Robert Green will share the latest results on the BabySeq Project, a randomized clinical trial exploring the benefits of genome sequencing on pediatric medical care.

Following the presentations, there was an extended live Q&A on the future of newborn screening and genomic medicine with both presenters.

Stephen F. Kingsmore, MD, DSc
President & CEO
Rady Children’s Institute for Genomic Medicine

Robert Green, MD
Professor of Genetics
Brigham & Women’s Hospital